There is a large amount of literature describing the potential of coumarins for the treatment of tumor- and inflammation-based diseases [47,48,49,50], which is based on the potent and selective action usually reported for coumarins against the CA IX and XII, involved in tumor progression [51]. This evidence concerns the gene CA9 and neoplasm.